Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Medical Center
Duarte, California, United States
Mina SedrakRecruiting - City of Hope at Irvine Lennar
Irvine, California, United States
Recruiting - City of Hope at Long Beach Elm
Long Beach, California, United States
Recruiting - City of Hope South Pasadena
South Pasadena, California, United States
Recruiting - Dana Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting - Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Mar 2020
- Primary completion
- 21 Aug 2026
- Completion
- 21 Aug 2026
- Last update posted
- 4 May 2026
- Registered enrollment
- 43
- Registry id
- NCT04305834
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.